• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞外基质影响 HGF/c-MET 信号通路:对癌症进展的影响。

Extracellular Matrix Influencing HGF/c-MET Signaling Pathway: Impact on Cancer Progression.

机构信息

Departamento de Biologia Celular e do Desenvolvimento, Instituto de Ciências Biomédicas, Universidade de São Paulo, Av. Prof. Lineu Prestes 1524, Prédio I, sala 428, 05508-000, São Paulo, SP, Brazil.

出版信息

Int J Mol Sci. 2018 Oct 24;19(11):3300. doi: 10.3390/ijms19113300.

DOI:10.3390/ijms19113300
PMID:30352967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6274944/
Abstract

The extracellular matrix (ECM) is a crucial component of the tumor microenvironment involved in numerous cellular processes that contribute to cancer progression. It is acknowledged that tumor⁻stromal cell communication is driven by a complex and dynamic network of cytokines, growth factors and proteases. Thus, the ECM works as a reservoir for bioactive molecules that modulate tumor cell behavior. The hepatocyte growth factor (HGF) produced by tumor and stromal cells acts as a multifunctional cytokine and activates the c-MET receptor, which is expressed in different tumor cell types. The HGF/c-MET signaling pathway is associated with several cellular processes, such as proliferation, survival, motility, angiogenesis, invasion and metastasis. Moreover, c-MET activation can be promoted by several ECM components, including proteoglycans and glycoproteins that act as bridging molecules and/or signal co-receptors. In contrast, c-MET activation can be inhibited by proteoglycans, matricellular proteins and/or proteases that bind and sequester HGF away from the cell surface. Therefore, understanding the effects of ECM components on HGF and c-MET may provide opportunities for novel therapeutic strategies. Here, we give a short overview of how certain ECM components regulate the distribution and activation of HGF and c-MET.

摘要

细胞外基质(ECM)是肿瘤微环境的重要组成部分,参与了许多细胞过程,这些过程有助于癌症的进展。人们已经认识到,肿瘤⁻基质细胞通讯是由细胞因子、生长因子和蛋白酶的复杂和动态网络驱动的。因此,ECM 作为生物活性分子的储存库,调节肿瘤细胞的行为。肿瘤和基质细胞产生的肝细胞生长因子(HGF)作为一种多功能细胞因子,激活在不同肿瘤细胞类型中表达的 c-MET 受体。HGF/c-MET 信号通路与多种细胞过程有关,如增殖、存活、迁移、血管生成、侵袭和转移。此外,c-MET 的激活可以被几种 ECM 成分促进,包括作为桥连分子和/或信号共受体的糖蛋白和蛋白聚糖。相反,c-MET 的激活可以被与 HGF 结合并将其从细胞表面隔离的蛋白聚糖、基质细胞蛋白和/或蛋白酶抑制。因此,了解 ECM 成分对 HGF 和 c-MET 的影响可能为新的治疗策略提供机会。在这里,我们简要概述了某些 ECM 成分如何调节 HGF 和 c-MET 的分布和激活。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/350d/6274944/896f35ae8335/ijms-19-03300-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/350d/6274944/896f35ae8335/ijms-19-03300-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/350d/6274944/896f35ae8335/ijms-19-03300-g001.jpg

相似文献

1
Extracellular Matrix Influencing HGF/c-MET Signaling Pathway: Impact on Cancer Progression.细胞外基质影响 HGF/c-MET 信号通路:对癌症进展的影响。
Int J Mol Sci. 2018 Oct 24;19(11):3300. doi: 10.3390/ijms19113300.
2
The biological role of HGF-MET axis in tumor growth and development of metastasis.肝细胞生长因子-间质-上皮转化因子轴在肿瘤生长和转移发展中的生物学作用。
Front Biosci. 2008 Jan 1;13:1271-80. doi: 10.2741/2760.
3
HGF/SF-met signaling in the control of branching morphogenesis and invasion.肝细胞生长因子/散射因子-间质表皮转化因子信号传导对分支形态发生和侵袭的调控
J Cell Biochem. 2003 Feb 1;88(2):408-17. doi: 10.1002/jcb.10358.
4
Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.肝细胞生长因子和Met在肿瘤生物学中的作用及NK4的治疗方法
Proteomics. 2008 Aug;8(16):3360-70. doi: 10.1002/pmic.200800156.
5
Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.转化生长因子-β信号缺陷型成纤维细胞增强乳腺癌细胞中的肝细胞生长因子信号,以促进细胞分散和侵袭。
Mol Cancer Res. 2008 Oct;6(10):1521-33. doi: 10.1158/1541-7786.MCR-07-2203.
6
Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.肝细胞生长因子和 c-Met 的共表达通过自分泌肝细胞生长因子/c-Met 信号预测胃癌腹膜转移的建立。
Int J Cancer. 2012 Jun 15;130(12):2912-21. doi: 10.1002/ijc.26330. Epub 2011 Sep 12.
7
Filamin a mediates HGF/c-MET signaling in tumor cell migration.细丝蛋白 A 介导肿瘤细胞迁移中的 HGF/c-MET 信号传导。
Int J Cancer. 2011 Feb 15;128(4):839-46. doi: 10.1002/ijc.25417.
8
CAF-derived HGF promotes cell proliferation and drug resistance by up-regulating the c-Met/PI3K/Akt and GRP78 signalling in ovarian cancer cells.癌相关成纤维细胞衍生的肝细胞生长因子通过上调卵巢癌细胞中的c-Met/PI3K/Akt和GRP78信号促进细胞增殖和耐药性。
Biosci Rep. 2017 Apr 10;37(2). doi: 10.1042/BSR20160470. Print 2017 Apr 28.
9
Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.对肝细胞生长因子具有治疗潜力的全人源单克隆抗体,可对抗依赖肝细胞生长因子/c-Met的人类肿瘤。
Cancer Res. 2006 Feb 1;66(3):1721-9. doi: 10.1158/0008-5472.CAN-05-3329.
10
Dysregulation of Type II Transmembrane Serine Proteases and Ligand-Dependent Activation of MET in Urological Cancers.尿路上皮癌中 II 型跨膜丝氨酸蛋白酶的失调和 MET 的配体依赖性激活。
Int J Mol Sci. 2020 Apr 11;21(8):2663. doi: 10.3390/ijms21082663.

引用本文的文献

1
In silico analysis to explore the therapeutic potential of propolis-derived small molecules as matriptase inhibitors to suppress breast cancer growth and metastasis.通过计算机模拟分析探索蜂胶衍生的小分子作为抑肽酶抑制剂抑制乳腺癌生长和转移的治疗潜力。
PLoS One. 2025 May 14;20(5):e0321687. doi: 10.1371/journal.pone.0321687. eCollection 2025.
2
Role of mitogens in normal and pathological liver regeneration.有丝分裂原在正常及病理性肝再生中的作用。
Hepatol Commun. 2025 Apr 30;9(5). doi: 10.1097/HC9.0000000000000692. eCollection 2025 May 1.
3
Engineered Expression of Hepatocyte Growth Factor Activator Inhibitor-1 (HAI-1) Reduces the Growth of Bladder Cancer Cells.

本文引用的文献

1
Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma.HGF/c-MET 酪氨酸激酶抑制剂在转移性黑色素瘤中的作用。
Mol Cancer. 2018 Feb 19;17(1):26. doi: 10.1186/s12943-018-0795-z.
2
Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2): Emerging key players in epithelial integrity and cancer.肝细胞生长因子激活剂抑制剂(HAI-1和HAI-2):上皮完整性和癌症中新兴的关键因子。
Pathol Int. 2018 Mar;68(3):145-158. doi: 10.1111/pin.12647. Epub 2018 Feb 12.
3
ADAMTS-1 disrupts HGF/c-MET signaling and HGF-stimulated cellular processes in fibrosarcoma.
肝细胞生长因子激活剂抑制剂-1(HAI-1)的工程化表达可降低膀胱癌细胞的生长。
Biomedicines. 2025 Apr 3;13(4):871. doi: 10.3390/biomedicines13040871.
4
Targeting HGF/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion.靶向HGF/c-MET信号传导以调节肿瘤微环境:对抗肿瘤免疫逃逸的意义。
Cell Commun Signal. 2025 Jan 25;23(1):46. doi: 10.1186/s12964-025-02033-1.
5
SE-lncRNAs in Cancer: Classification, Subcellular Localisation, Function and Corresponding TFs.癌症中的SE-lncRNAs:分类、亚细胞定位、功能及相应转录因子
J Cell Mol Med. 2024 Dec;28(24):e70296. doi: 10.1111/jcmm.70296.
6
Proteomic analysis reveals key differences in pro-stromal corneal tissue between highly myopic males and females.蛋白质组学分析揭示了高度近视男性和女性之间角膜前基质组织的关键差异。
Front Med (Lausanne). 2024 Aug 16;11:1406748. doi: 10.3389/fmed.2024.1406748. eCollection 2024.
7
Glucocorticoids in lung cancer: Navigating the balance between immunosuppression and therapeutic efficacy.肺癌中的糖皮质激素:把握免疫抑制与治疗效果之间的平衡。
Heliyon. 2024 Jun 4;10(12):e32357. doi: 10.1016/j.heliyon.2024.e32357. eCollection 2024 Jun 30.
8
Targeting the hedgehog pathway in MET mutation cancers and its effects on cells associated with cancer development.针对 MET 突变癌症中的 hedgehog 通路及其对与癌症发展相关的细胞的影响。
Cell Commun Signal. 2023 Nov 2;21(1):313. doi: 10.1186/s12964-023-01333-8.
9
Rimonabant and Cannabidiol Rewrite the Interactions between Breast Cancer Cells and Tumor Microenvironment.利莫那班和大麻二酚改写了乳腺癌细胞与肿瘤微环境之间的相互作用。
Int J Mol Sci. 2023 Aug 30;24(17):13427. doi: 10.3390/ijms241713427.
10
Targeting the tumor stroma for cancer therapy.针对肿瘤基质的癌症治疗。
Mol Cancer. 2022 Nov 2;21(1):208. doi: 10.1186/s12943-022-01670-1.
ADAMTS-1 破坏成纤维肉瘤中的 HGF/c-MET 信号和 HGF 刺激的细胞过程。
Exp Cell Res. 2018 Feb 15;363(2):271-282. doi: 10.1016/j.yexcr.2018.01.017. Epub 2018 Jan 31.
4
HGF potentiates extracellular matrix-driven migration of human myoblasts: involvement of matrix metalloproteinases and MAPK/ERK pathway.HGF 增强人肌母细胞的细胞外基质驱动迁移:基质金属蛋白酶和 MAPK/ERK 通路的参与。
Skelet Muscle. 2017 Oct 10;7(1):20. doi: 10.1186/s13395-017-0138-6.
5
Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer.交联激活的 c-Met/β1 整合素复合物促进癌症转移和侵袭抵抗。
Proc Natl Acad Sci U S A. 2017 Oct 10;114(41):E8685-E8694. doi: 10.1073/pnas.1701821114. Epub 2017 Sep 26.
6
Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance.化疗药物暴露后或对耐药性进行选择时肿瘤细胞中炎性细胞因子的产生。
PLoS One. 2017 Sep 15;12(9):e0183662. doi: 10.1371/journal.pone.0183662. eCollection 2017.
7
Targeting the hepatocyte growth factor/Met pathway in cancer.靶向癌症中的肝细胞生长因子/Met通路。
Biochem Soc Trans. 2017 Aug 15;45(4):855-870. doi: 10.1042/BST20160132. Epub 2017 Jul 3.
8
HGF/c-MET Axis in Tumor Microenvironment and Metastasis Formation.肿瘤微环境与转移形成中的HGF/c-MET轴
Biomedicines. 2015 Jan 22;3(1):71-88. doi: 10.3390/biomedicines3010071.
9
c-Met and Other Cell Surface Molecules: Interaction, Activation and Functional Consequences.c-Met 及其他细胞表面分子:相互作用、激活与功能后果
Biomedicines. 2015 Jan 15;3(1):46-70. doi: 10.3390/biomedicines3010046.
10
Progress of antibody-based inhibitors of the HGF-cMET axis in cancer therapy.基于抗体的HGF-cMET轴抑制剂在癌症治疗中的进展
Exp Mol Med. 2017 Mar 24;49(3):e307. doi: 10.1038/emm.2017.17.